Medy-Tox Market Cap

Medy-Tox has a market cap or net worth of 816.4 billion as of January 16, 2026. Its market cap has decreased by -5.25% in one year.

Market Cap

816.40B

Enterprise Value

836.64B

Revenue

241.80B

Ranking

n/a

PE Ratio

34.22

Stock Price

116,300.00

Market Cap Chart

Since January 16, 2009, Medy-Tox's market cap has increased from 71.73B to 816.40B, an increase of 1,038.23%. That is a compound annual growth rate of 15.36%.

Market Cap History

Date	Market Cap	% Change
Jan 19, 2026	816.40B	-3.73%
Dec 30, 2025	847.99B	2.03%
Dec 30, 2024	831.10B	-48.75%
Dec 28, 2023	1.62T	101.16%
Dec 29, 2022	806.18B	-7.99%
Dec 30, 2021	876.20B	-13.91%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	90.13T
Celltrion	45.73T
ALTEOGEN	27.70T
ABL Bio	10.89T
SK Biopharmaceuticals	9.43T
Yuhan	8.05T
HLB Co., Ltd.	6.97T
Sam Chun Dang Pharm.	6.49T

Market Cap Rankings